Upsher-Smith launches mesalamine extended-release capsules
MAPLE GROVE, Minn. – Upsher-Smith announced the recent launch of mesalamine extended-release capsules, USP 375 mg. The mesalamine capsule market had U.S. sales of approximately $105 million for the 12 months ending June 2023 according to IQVIA.